American Regent, Inc. Issues Voluntary Nationwide Recall of One Lot of Papaverine Hydrochloride Injection, USP 60 mg/ 2 mL Due to the Presence of Visible Particulate Matter
Publisher
USA
This page provides a limited summary and publisher metadata to support discovery before sending readers to the original article.
Read originalAt a glance
- Publisher
- FDA Drug Safety Communications
- Region
- USA
- Scope
- Regulatory
- Published
- July 27, 2026
- Language
- EN
In-platform summary, original article off-platform
This page presents the title, publisher metadata, and a limited summary excerpt to help users judge relevance first. Full-text reading stays on the publisher's original site.
Source route
Continue on fda.gov
Leave the platform to read the original full article on the publisher site.
Source: FDA Drug Safety Communications
Scope: Regulatory
Related coverage
More related coverage
Medicine supply disruption statistics, UK: data to June 2026
Twice-yearly official statistics on medicine supply issue and discontinuation notifications reported...
UKHSA updates heat health alerts across England
An amber heat-health alert has been issued for the East Midlands, East of England, South East and Lo...
Working for UKHSA
Learn about the UK Health Security Agency, including who we are, what we do, available opportunities...
DHSC: workforce management information
Documents relating to workforce management information summary data for the Department of Health and...